Lolkje TW De Jong - van den Berg

Summary

Affiliation: University of Groningen
Country: The Netherlands

Publications

  1. ncbi HRT use in 2001 and 2004 in The Netherlands--a world of difference
    Lolkje T W de Jong-van den Berg
    Groningen University Institute for Drug Exploration GUIDE, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
    Maturitas 54:193-7. 2006
  2. ncbi Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
    H Dolk
    Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute for Drug Exploration GUIDE, University of Groningen, The Netherlands, Ant Deusinglaan 1, 9713 AV Groningen The Netherlands
    Neurology 71:714-22. 2008
  3. ncbi Patient-reporting of side effects may provide an important source of information in clinical practice
    Juliet M Foster
    Eur J Clin Pharmacol 63:979-80; author reply 981. 2007
  4. ncbi Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial
    Janna M Munster
    University of Groningen, University Centre for Pharmacy, Pharmacoepidemiology and Pharmacoeconomics, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    BMC Womens Health 10:32. 2010

Collaborators

Detail Information

Publications4

  1. ncbi HRT use in 2001 and 2004 in The Netherlands--a world of difference
    Lolkje T W de Jong-van den Berg
    Groningen University Institute for Drug Exploration GUIDE, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
    Maturitas 54:193-7. 2006
    ..Therefore, we compare the prescribing of HRT in 2004 (after) with that of 2001 (before the publications) in The Netherlands...
  2. ncbi Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
    H Dolk
    Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute for Drug Exploration GUIDE, University of Groningen, The Netherlands, Ant Deusinglaan 1, 9713 AV Groningen The Netherlands
    Neurology 71:714-22. 2008
    ....
  3. ncbi Patient-reporting of side effects may provide an important source of information in clinical practice
    Juliet M Foster
    Eur J Clin Pharmacol 63:979-80; author reply 981. 2007
  4. ncbi Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial
    Janna M Munster
    University of Groningen, University Centre for Pharmacy, Pharmacoepidemiology and Pharmacoeconomics, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    BMC Womens Health 10:32. 2010
    ..We designed a trial to assess the (cost-)effectiveness of a screening program for Q fever in pregnant women living in risks areas in The Netherlands...